Inhibition of poly(ADP-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass

Shock

Volumn 25, Issue 2, 2006, Pages 168-175

  Yeh, Chi Hsiao ^a   Chen, Tzu Ping ^a   Lee, Chieh Hung ^a   Wu, Yi Chen ^a   Lin, Yu Min ^a   Pyng, Jing Lin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Ischemia reperfusion injury; Poly(ADP ribose) polymerase; Reactive oxygen species

Indexed keywords

AMINOBENZOIC ACIDS; ANIMALS; APOPTOSIS; BENZAMIDES; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; ENZYME INHIBITORS; HEART ARREST; MALE; MYOCYTES, CARDIAC; POLY(ADP-RIBOSE) POLYMERASES; RABBITS; REPERFUSION INJURY;

EID: 33646768219     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000188709.04777.48     Document Type: Article

References (37)

1. Wallace A, Lam HW, Nose PS, Bellows W, Mangano DT: Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg 9(suppl 3):497-502, 1994.
2. Szabó G, Bährle S, Stumpf N, Sonnenberg K, Szabó É, Pacher P, Csont T, Schulz R, Dengler TJ, Liaudet L, Jagtap PG, Southan GJ, Vahl CF, Hagl S, Szabó C: Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90:100-106, 2002.
3. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990.
4. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4:3355-3359, 1990.
5. Farivar AS, Woolley SM, Fraga CH, Thomas R, Salzman AL, Szabó C, Mulligan MS: Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. Ann Thorac Surg 77:1938-1943, 2004.
6. Bouchard VJ, Rouleau M, Poirier GG: PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol 31:446-454, 2003.
7. Hassa PO, Hottiger MO: A role of poly (ADP-ribose) polymerase in NF-κB transcriptional activation. Biol Chem 380:953-959, 1999.
8. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263, 2002.
9. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G: Resistance to endotoxic shock as a consequence of defective NF κB activation in poly (ADP) ribose polymerase-1 deficient mice. EMBO J 18:4446-4454, 1999.
10. Sharp C, Warren A, Oshima T, Williams L, Li JH, Alexander JS: Poly ADP ribose-polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. Inflammation 25:157-163, 2001.
11. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G: Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14:729-739, 2000.
12. Szabados E, Fisher MG, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 26:309-317, 1999.
13. Ha HC, Hester LD, Snyder SH: Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 99:3270-3275, 2002.
14. Mizumoto K, Glascott PA Jr, Farber JL: Roles of oxidative stress and poly (ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methanesulfonate. Biochem Pharmacol 46:1811-1818, 1993.
15. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel F, Burkhart V, Kolb H: Inactivation of the poly (ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270:11176-11180, 1995.
16. Said SI, Berisha HI, Pakbaz H: Excitotoxicity in the lung: N-methyl-D-asparate-induced, nitric oxide-dependent, pulmonary edema is attenuated vasoactive intestinal peptide and by inhibitors of poly (ADP-ribose) polymerase. Proc Natl Acad Sci USA 93:4688-4692, 1996.
17. Thiemermann C, Bowes J, Myint FP, Vane JR: Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94:679-683, 1997.
18. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure. Circ Res 78:1051-1063, 1996.
19. Virág L, Scott GS, Cuzzocrea S, Salzman AL, Szabó C: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly-(ADP-ribose) synthetase (PARS) activation. Immunology 94:345-355, 1998.
20. Szabó C, Dawson VL: Role of poly (ADP ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol Sci 19:287-298, 1998.
21. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabo C: Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 36:205-215, 1997.
22. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL: Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100:723-735, 1997.
23. Bowes J, McDonald MC, Piper J, Thiemermann C: Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. Cardiovasc Res 41:126-134, 1999.
24. Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ: Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocytic apoptosis. Chest 123:1647-1654, 2003.
25. Mehlhorn U, Krahwinkel A, Geissler HJ, LaRosee K, Fischer UM, Klass O, Suedkamp M, Hekmat K, Tossios P, Bloch W: Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg 125:178-183, 2003.
26. Zingarelli B, Salzman AL, Szabo C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94, 1998.
27. Chen M, Zsengellér Z, Xiao CY, Szabó C: Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc Res 63:682-688, 2004.
28. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 99:6252-6256, 2002.
29. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809, 1995.
30. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares H, Smulson ME: Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol Cell Biochem 193:137-148, 1999.
31. Nguewa PA, Fuertes MA, Valladares B, Alonso C, Pérex JM: Poly(ADP-ribose) polymerases: Homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 88:143-172, 2005.
32. Szabó G, Buhmann V, Andrási T, Stumpf N, Bährle S, Kékesi V, Hagl S, Szabó C, Juhász-Nagy A: Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest. J Thorac Cardiovasc Surg 126:651-658, 2003.
33. Pétrilli V, Herceg Z, Hassa PO, Patel NSA, Di Paola R, Cortes U, Dugo L, Filipe H-M, Thiemermann C, Hottiger MO, Cuzzocrea S, Wang Z-Q: Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest 114:1072-1081, 2004.
34. Vanden Hoek TL, Qin Y, Wojcik K, Li C-Q, Shao Z-H, Anderson T, Becker LB, Hamann KJ: Reperfusion, not simulated ischemia, initiates intrinsic apoptosis injury in chick cardiomyocytes. Am J Physiol Heart Circ Physiol 284:H141-H150, 2003.
35. Granville DJ, Cassidy BA, Ruehlmann DO, Choy JC, Brenner C, Kroemer G, van Breemen C, Margaron P, Hunt DW, McManus BM: Mitochondrial release of apoptosis-inducing factor and cytochrome c during smooth muscle cell apoptosis. Am J Pathol 159:305-311, 2001.
36. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446, 1999.
37. Kher A, Wang M, Tsai BM, Pitcher JM, Greenbaum ES, Nagy RD, Patel KM, Wairiuko GM, Markel TA, Meldrum DR: Sex differences in the myocardial inflammatory response to acute injury. Shock 23:1-10, 2005.